Inhibition of Progression of Heart Failure and Expression of TGF-β1 mRNA in Rats with Heart Failure by the ACE Inhibitor Quinapril
- 1 October 2001
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Cardiovascular Pharmacology
- Vol. 38, S51-S54
- https://doi.org/10.1097/00005344-200110001-00011
Abstract
The cardioprotective effects of quinapril, an angiotensin-converting enzyme inhibitor, were studied in a rat model of heart failure. Twenty-six rats were divided into two groups: one given 20 mg/kg/day quinapril (n = 11), and controls given 0.5% methylcellulose (n = 15). After oral administration for 1 month, quinapril reduced heart weight (from 1.28+/-0.05 to 0.87+/-0.02 g; p < 0.05) without changing body weight. Quinapril lowered left ventricular end-diastolic pressure (from 14.1+/-2.0 to 6.6+/-1.5 mmHg; p < 0.05) and central venous pressure (from 2.7+/-0.9 to 0.7+/-0.4 mmHg), and increased +/- dP/dt (from +2409+/-50 to +3569+/-169 mmHg/s, and from -2318+/-235 to -3960+/-203 mmHg/s; both p < 0.01). The area of myocardial fibrosis was markedly reduced by quinapril (6+/-3%) as compared with controls (29+/-6%; p < 0.01). Expression of transforming growth factor (TGF)-beta1 mRNA was markedly increased in controls as compared with age-matched normal rats. The increase in level of TGF-beta1 mRNA was significantly suppressed by quinapril (from 17.1+/-6.2 to 9.00+/-2.40; p < 0.05). These observations indicated that quinapril has cardioprotective effects on heart failure, and that the beneficial effects may be partly explained by attenuation of fibrotic response through suppression of TGF-beta1 mRNA expression.Keywords
This publication has 14 references indexed in Scilit:
- Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathyBritish Journal of Pharmacology, 2000
- Carvedilol Enhances Atrial and Brain Natriuretic Peptide mRNA Expression and Release in Rat HeartJournal of Cardiovascular Pharmacology, 2000
- Effects of quinapril, losartan and hydralazine on cardiac hypertrophy andβ-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 ratsBritish Journal of Pharmacology, 1998
- ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritisKidney International, 1995
- Molecular signalling mechanisms controlling growth and function of cardiac fibroblastsCardiovascular Research, 1995
- Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes.JCI Insight, 1994
- Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components.Circulation Research, 1994
- Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.JCI Insight, 1994
- Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat.Circulation Research, 1994
- Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failureJournal of the American College of Cardiology, 1985